Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
AI in healthcare and wearables are buzzy words in the sector, but not all patients are on board with injecting biometric monitoring devices (BMDs) into their daily lives. And that non-acceptance could prove problematic for the future of these devices and other AI-based tools, according to a recent study from French researchers with Université Paris Descartes.
A not-for-profit drug company startup founded by health foundations and providers, Civica Rx, has teamed up with analytics and advisory company Vizient to address drug shortages.
A Berlin-based startup whose mobile health app uses AI to help people manage chronic digestive problems has raised $7 million in Series A funding. The company intends to spend the bulk of the money getting the app in the hands of gastrointestinal patients in the U.S.
Researchers have developed an algorithm to help assess the response of Parkinson’s patients to medication while clinicians are at work and the patients are typing on personal computers in their homes.
Researchers have demonstrated two machine learning techniques that, when combined to analyze social-media posts, can boost early detection of clinical depression by 10% over the current state of the art.
Kaiser Permanente, the Oakland, California-based health system, is building a new headquarters in the same city. The new headquarters, which is called Kaiser Permanente Thrive Center and will accommodate 7,200 national and Northern California Region employees and physicians, comes with a price tag of about $900 million, according to the San Francisco Chronicle.
